Gainers
- Veru Inc. (NASDAQ:VERU) shares jumped 62.5% to $14.67 after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to $55.
- Inotiv, Inc. (NASDAQ:NOTV) gained 36.6% to $16.33 after the company reported better-than-expected Q2 results.
- Duolingo, Inc. (NASDAQ:DUOL) rose 36.1% to $91.17 after the company reported better-than-expected Q1 EPS and sales results.
- Payoneer Global Inc. (NASDAQ:PAYO) gained 31.3% to $4.7250 after the company reported better-than-expected Q1 EPS and sales results and issued FY22 sales guidance above analyst estimates.
- Dave Inc. (NASDAQ:DAVE) rose 28.2% to $3.00 following Q1 results.
- Celularity Inc. (NASDAQ:CELU) surged 26.8% to $7.32.
- indie Semiconductor, Inc. (NASDAQ:INDI) gained 25.9% to $6.80 after the company reported better-than-expected Q1 EPS and sales results.
- TScan Therapeutics, Inc. (NASDAQ:TCRX) jumped 25.7% to $2.64.
- Lightspeed Commerce Inc. (NYSE:LSPD) jumped 25% to $20.22.
- Blend Labs, Inc. (NASDAQ:BLND) gained 24.4% to $3.7950 after the company reported better-than-expected Q1 sales results and reaffirmed FY22 sales guidance.
- Expensify, Inc. (NASDAQ:EXFY) rose 24.3% to $18.95 after the company posted Q1 results and announced a $50 million buyback program.
- MicroStrategy Incorporated (NASDAQ:MSTR) jumped 24.1% to $212.47.
- Dynavax Technologies Corporation (NASDAQ:DVAX) gained 23.8% to $9.81. Dynavax Technologies is set to join S&P SmallCap 600.
- SomaLogic, Inc. (NASDAQ:SLGC) surged 23.8% to $5.63 after reporting Q1 results.
- Silvergate Capital Corporation (NYSE:SI) gained 23.8% to $78.93.
- CleanSpark, Inc. (NASDAQ:CLSK) gained 23.3% to $6.34. Cleanspark recently posted Q2 sales of $41.60 million.
- Asana, Inc. (NYSE:ASAN) climbed 23.3% to $24.51.
- Alpha and Omega Semiconductor Limited (NASDAQ:AOSL) jumped 23% to $40.83 after it was announced the company will replace Mimecast in the S&P SmallCap 600.
- Robinhood Markets, Inc. (NASDAQ:HOOD) shares rose 22.6% to $10.49 after a 13D filing showed Samuel Bankman-Fried, founder and CEO of FTX crypto exchange, disclosed a 7.6% stake in the company.
- Affirm Holdings, Inc. (NASDAQ:AFRM) shares gained 22.5% to $22.10 after the company reported upbeat results for its third quarter and raised its revenue forecast for the fiscal year. The company also announced a multi-year extension of its partnership in the U.S. with Shopify.
- CTI BioPharma Corp. (NASDAQ:CTIC) rose 22.2% to $4.4750 following upbeat quarterly results.
- Joby Aviation, Inc. (NASDAQ:JOBY) gained 21.4% to $5.38 after the company reported better-than-expected Q1 EPS results.
- Calithera Biosciences, Inc. (NASDAQ:CALA) rose 20.7% to $0.1945. The company recently reported a net loss of $13.8 million for the three months ended March 31, 2022.
- Laird Superfood, Inc. (NYSE:LSF) gained 20.4% to $2.65 following strong quarterly sales.
- Viridian Therapeutics, Inc. (NASDAQ:VRDN) jumped 20.4% to $12.72 following 1 earnings.
- EQRx, Inc. (NASDAQ:EQRX) gained 19.3% to $3.95 following Q1 results.
- Cloudflare, Inc. (NYSE:NET) jumped 18.4% to $67.19.
- C3.ai, Inc. (NYSE:AI) gained 17.9% to $17.17.
- Lightwave Logic, Inc. (NASDAQ:LWLG) gained 17.8% to $8.16.
- WeWork Inc. (NYSE:WE) jumped 17.7% to $6.63. WeWork posted a Q1 loss of $0.57 per share.
- Graphite Bio, Inc. (NASDAQ:GRPH) jumped 17.5% to $2.68 after the company posted a narrower Q1 loss.
- Ryder System, Inc. (NYSE:R) gained 17.2% to $83.75. Ryder 13D Filing from HG Vora showed the company issued proposal to acquire all shares of company’s common stock at $86 per share.
- The RealReal, Inc. (NASDAQ:REAL) rose 16.9% to $3.7650 after dipping around 6% on Thursday.
- Array Technologies, Inc. (NASDAQ:ARRY) gained 16.1% to $7.20. Array Technologies recently reported Q1 earnings results and issued FY22 adjusted EPS guidance below estimates.
- Beyond Meat, Inc. (NASDAQ:BYND) gained 15.6% to $29.00. Beyond Meat recently reported worse-than-expected Q1 EPS and sales results.
- Molecular Partners AG (NASDAQ:MOLN) rose 15.4% to $6.91. Molecular Partners recently said its partner Novartis expects the FDA may require additional clinical data for the Emergency Use Application for ensovibep.
- Bill.com Holdings, Inc. (NASDAQ:BILL) gained 15.4% to $115.28.
- Fangdd Network Group Ltd. (NASDAQ:DUO) rose 11.5% to $0.2401 after gaining around 8% on Thursday.
- McEwen Mining Inc. (NYSE:MUX) rose 10.5% to $0.51. McEwen Mining recently posted a Q1 loss of $0.04 per share.
- Landos Biopharma, Inc. (NASDAQ:LABP) rose 7.7% to $0.72 after the company said Q1 EPS results were higher year over year.
- Redwire Corporation (NYSE:RDW) rose 6.5% to $3.94 following Q1 results.
Losers
- LiqTech International, Inc. (NASDAQ:LIQT) shares dipped 44.8% to $0.5052 after the company priced its public offering of common stock and pre-funded warrants.
- Actelis Networks Inc. (NASDAQ:ASNS) shares fell 29.3% to $2.8290 after the company priced its IPO at $4 per share.
- FIGS, Inc. (NYSE:FIGS) dropped 27% to $9.38 after the company reported worse-than-expected Q1 adjusted EPS and sales results and cut FY22 sales guidance to below analyst estimates.
- Brilliant Earth Group, Inc. (NASDAQ:BRLT) fell 25.9% to $5.00 after the company reported issued Q2 and FY22 net sales guidance below analyst estimates.
- Tenon Medical, Inc. (NASDAQ:TNON) dipped 21.6% to $6.95.
- Stealth BioTherapeutics Corp (NASDAQ:MITO) fell 13.5% to $0.2161. Stealth BioTherapeutics shares jumped around 32% on Thursday after the company announced the FDA has granted Orphan Drug Designation for elamipretide for the treatment duchenne muscular dystrophy.
- Enfusion, Inc. (NYSE:ENFN) dropped 13.1% to $8.70 after the company reported worse-than-expected Q1 EPS results.
- Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) shares fell 13.1% to $0.1929. Salarius Pharmaceuticals posted a Q1 loss of $0.13 per share.
- Angel Oak Mortgage, Inc. (NYSE:AOMR) dropped 13% to $12.81 after reporting a loss for the first quarter.
- Digimarc Corporation (NASDAQ:DMRC) dropped 12.4% to $17.70 following weak quarterly results.
- Twitter, Inc. (NYSE:TWTR) fell 9.2% to $40.93. After running the hard mile to mobilize finances for his Twitter buy, Elon Musk said early Friday the deal is on hold.
- Xponential Fitness, Inc. (NYSE:XPOF) dipped 8.9% to $15.15 after reporting a loss for the first quarter.
- Regulus Therapeutics Inc. (NASDAQ:RGLS) fell 8.4% to $0.2250. Regulus Therapeutics posted a Q1 loss of $0.05 per share.
- Arteris, Inc. (NASDAQ:AIP) declined 7.4% to $8.56.
- Sky Harbour Group Corporation (NYSE:SKYH) fell 5.5% to $8.16 after reporting Q1 results.
